In Vivo Modulation of the N-Methyl-D-Aspartate Receptor Complex by D-Serine: Potentiation of Ongoing Neuronal Activity as Evidenced by Increased Cerebellar Cyclic GMP
Abstract
Direct intracerebellar injections of TV-methyl-D-aspartate (NMDA) or D-serine elicited dose-dependent increases in cerebellar cyclic GMP levels, in vivo in the mouse. The actions of D-serine were antagonized by the competitive NMDA receptor antagonist 3-(2-carboxypiperazin-4-yl) propyl-1-phosphonic acid and by the phen-cyclidine receptor agonist MK-801, observations supporting actions at the NMDA-coupled glycine receptor. In addition, the actions of D-serine were antagonized by a partial agonist (D-cycloserine) and an antagonist (HA-966) of the NMDA-coupled glycine receptor. These data are all consistent with D-serine acting at the NMDA-coupled glycine receptor and represent the first demonstration of glycine receptor potentiation of ongoing NMDA-mediated neuronal activity in the CNS, rather than potentiation of exogenous NMDA.
Abbreviations used:
-
- cGMP
-
- cyclic GMP
-
- CPP
-
- 3-(2-carboxypiper-azin-4-yl)propyl-l-phosphonic acid
-
- HA-966
-
- l-hydroxy-3-amino-pyrrolidone-2
-
- NMDA
-
- N-methyl-D-aspartate
-
- PCP
-
- phencyclidine